We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$25.3M
(+4.5%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$3.6M |
| 2 |
NVIDIA
NVDA
|
+$1.81M |
| 3 |
Natera
NTRA
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$1.41M |
| 5 |
SentinelOne
S
|
+$706K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.86M |
| 2 |
Microsoft
MSFT
|
+$2.82M |
| 3 |
Mastercard
MA
|
+$2.78M |
| 4 |
Comcast
CMCSA
|
+$2.56M |
| 5 |
Apple
AAPL
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35% |
| 2 | Healthcare | 14.27% |
| 3 | Consumer Discretionary | 13.55% |
| 4 | Communication Services | 11.79% |
| 5 | Financials | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.82T
| $68.2M | 11.65% |
383,900
-16,143
| -4% | -$2.55M |
|
|
2
Microsoft
MSFT
$2.98T
| $60.7M | 10.37% |
180,422
-8,698
| -5% | -$2.82M |
|
3
Amazon
AMZN
$2.68T
| $30.9M | 5.27% |
185,140
-8,720
| -4% | -$1.49M |
|
4
Alphabet (Google) Class A
GOOGL
$4.3T
| $21M | 3.59% |
145,120
-6,840
| -5% | -$985K |
|
|
5
NVIDIA
NVDA
$4.91T
| $20.4M | 3.49% |
694,930
+65,920
| +10% | +$1.81M |
|
|
6
Alphabet (Google) Class C
GOOG
$4.29T
| $19.4M | 3.32% |
134,420
-6,940
| -5% | -$1M |
|
7
Meta Platforms (Facebook)
META
$1.65T
| $15.6M | 2.67% |
46,379
-3,832
| -8% | -$1.27M |
|
8
Thermo Fisher Scientific
TMO
$196B
| $11.9M | 2.04% |
17,848
-1,007
| -5% | -$629K |
|
9
Costco
COST
$414B
| $11.6M | 1.99% |
20,511
-991
| -5% | -$508K |
|
|
10
Mastercard
MA
$483B
| $10.2M | 1.75% |
28,442
-8,053
| -22% | -$2.78M |
|
|
11
Visa
V
$687B
| $9.95M | 1.7% |
45,891
-22,655
| -33% | -$4.86M |
|
12
S&P Global
SPGI
$133B
| $7.44M | 1.27% |
15,767
-831
| -5% | -$380K |
|
13
TJX Companies
TJX
$172B
| $7.26M | 1.24% |
95,623
-4,642
| -5% | -$322K |
|
14
Home Depot
HD
$332B
| $6.91M | 1.18% |
16,642
-854
| -5% | -$325K |
|
15
UnitedHealth
UNH
$385B
| $6.49M | 1.11% |
12,919
-3,818
| -23% | -$1.73M |
|
|
16
Pfizer
PFE
$141B
| $6.36M | 1.09% |
107,747
+28,390
| +36% | +$1.41M |
|
17
PayPal
PYPL
$50.1B
| $6.23M | 1.06% |
33,040
-1,722
| -5% | -$373K |
|
18
Roper Technologies
ROP
$36.7B
| $6.21M | 1.06% |
12,625
-708
| -5% | -$337K |
|
19
Eli Lilly
LLY
$1.03T
| $6.04M | 1.03% |
21,863
-948
| -4% | -$240K |
|
20
DexCom
DXCM
$29.4B
| $5.47M | 0.94% |
40,760
-6,064
| -13% | -$871K |
|
21
Applied Materials
AMAT
$419B
| $5.46M | 0.93% |
34,698
-1,498
| -4% | -$217K |
|
22
Bank of America
BAC
$425B
| $5.37M | 0.92% |
120,618
-6,660
| -5% | -$303K |
|
23
JPMorgan Chase
JPM
$899B
| $5.2M | 0.89% |
32,866
-1,714
| -5% | -$281K |
|
24
Estee Lauder
EL
$30.1B
| $5.17M | 0.88% |
13,975
-606
| -4% | -$206K |
|
25
Qualcomm
QCOM
$181B
| $5.16M | 0.88% |
28,227
-1,017
| -3% | -$163K |
|
Similar funds
ZF
AG
NRCM
CWM
BAM
PFM
DMIC
LIP
Silvant Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.
- Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
- Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
- Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
- Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
- Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
- Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
- Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.
Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.